Clonal dynamics of haematopoiesis across the human lifespan.

Mitchell E, Spencer Chapman M, Williams N, Dawson KJ, Mende N, Calderbank EF, Jung H, Mitchell T, Coorens THH, Spencer DH, Machado H, Lee-Six H, Davies M, Hayler D, Fabre MA, Mahbubani K, Abascal F, Cagan A, Vassiliou GS, Baxter J, Martincorena I, Stratton MR, Kent DG, Chatterjee K, Parsy KS, Green AR, Nangalia J, Laurenti E, Campbell PJ. · 2022

Read Clonal dynamics of haematopoiesis across the human lifespan. by Mitchell E, Spencer Chapman M, Williams N, Dawson KJ, Mende N, Calderbank EF, Jung H, Mitchell T, Coorens THH, Spencer DH, Machado H, Lee-Six H, Davies M, Hayler D, Fabre MA, Mahbubani K, Abascal F, Cagan A, Vassiliou GS, Baxter J, Martincorena I, Stratton MR, Kent DG, Chatterjee K, Parsy KS, Green AR, Nangalia J, Laurenti E, Campbell PJ. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9177428.txt.

Introduction

Mitchell and co-authors map clonal dynamics of blood formation across the human lifespan. Blood-forming stem cells lose regenerative power with age, and blood cancer risk rises. Why function drops sharply after age 70 was unclear. The team sequenced 3,579 genomes from single cell-derived colonies in 10 people aged 0 to 81.

Stem cells gained a mean of 17 mutations per year after birth. Blood production stayed richly diverse in adults under 65, with vast numbers of stem cells sharing the work. After 75, diversity fell sharply, and a few dozen clones supplied much of the blood. Most of those clones began expanding before age 40. Simulations with steady driver gains explained the abrupt shift well.

Catalog record

CREATORMitchell E, Spencer Chapman M, Williams N, Dawson KJ, Mende N, Calderbank EF, Jung H, Mitchell T, Coorens THH, Spencer DH, Machado H, Lee-Six H, Davies M, Hayler D, Fabre MA, Mahbubani K, Abascal F, Cagan A, Vassiliou GS, Baxter J, Martincorena I, Stratton MR, Kent DG, Chatterjee K, Parsy KS, Green AR, Nangalia J, Laurenti E, Campbell PJ.
YEAR2022
COLLECTIONPAPERS
FORMATTXT
FILE SIZE97 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC9177428

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Clonal dynamics of haematopoiesis across the human lifespan By Emily Mitchell, Michael Spencer Chapman, Nicholas Williams, Kevin J Dawson, Nicole Mende, Emily F Calderbank, Hyunchul Jung, Thomas Mitchell, Tim H H Coorens, David H Spencer, Heather Machado, Henry Lee-Six Published in: Nature DOI: 10.1038/s41586-022-04786-y ABSTRACT Abstract Age-related change in human haematopoiesis causes reduced regenerative capacity1, cytopenias2, immune dysfunction3 and increased risk of blood cancer4–6, but the reason for such abrupt functional decline after 70 years of age remains unclear. Here we sequenced 3,579 genomes from single cell-derived colonies of haematopoietic cells across 10 human subjects from 0 to 81 years of age. Haematopoietic stem cells or multipotent progenitors (HSC/MPPs) accumulated a mean of 17 mutations per year after birth and lost 30 base pairs per year of telomere length. Haematopoiesis in adults less than 65 years of age was massively polyclonal, with high clonal diversity and a stable population of 20,000–200,000 HSC/MPPs contributing evenly to blood production. By contrast, haematopoiesis in individuals aged over 75 showed profoundly decreased clonal diversity. In each of the older subjects, 30–60% of haematopoiesis was accounted for by 12–18 independent clones, each contributing 1–34% of blood production. Most clones had begun their expansion before the subject was 40 years old, but only 22% had known driver mutations. Genome-wide selection analysis estimated that between 1 in 34 and 1 in 12 non-synonymous mutations were drivers, accruing at constant rates throughout life, affecting more genes than identified in blood cancers. Loss of the Y chromosome conferred selective benefits in males. Simulations of haematopoiesis, with constant stem cell population size and constant acquisition of driver mutations conferring moderate fitness benefits, entirely explained the abrupt change in clonal structure in the elderly. Rapidly decreasing clonal diversity is a universal feature of haematopoiesis in aged humans, underpinned by pervasive positive selection acting on many more genes than currently identified. Subject terms: Mutation, Ageing, Haematopoiesis, Genomics, Risk factors MAIN The age-related mortality curve for modern humans is an outlier across the tree of life, with an abrupt increase in mortality after the average lifespan7, leading to surprisingly low variance in age at death8. Studies of ageing at the cellular level have demonstrated that accumulation of molecular damage across the lifespan is gradual and lifelong, including telomere attrition, somatic mutation, epigenetic change and oxidative or replicative stress9. It remains unresolved how such gradual accumulation of molecular damage can translate into an abrupt increase in mortality after 70 years of age. Sequencing of blood samples from population cohorts has revealed an age-related increase in acquired mutations in genes that cause myeloid neoplasms4,5,10–12, known as driver mutations. This phenomenon is called clonal haematopoiesis, and reaches 10–20% prevalence4,5,10–12 or higher13 after 70 years of age, but the driver mutations typically account for only a small fraction of haematopoiesis (less than 5% of cells). Some elderly individuals show evidence of clonal expansions even in the absence of known driver mutations14–16. Deep sequencing of bulk blood samples, as used in these studies, struggles to elucidate clonal relationships among cells and is insensitive to mutations that are present in a low proportion (below 1–5%) of blood cells—as a result, we lack an unbiased, high-resolution model for the clonal dynamics of human haematopoiesis with ageing. Whole-genome sequencing of colonies grown from single cells circumvents these limitations of bulk sequencing17–19. We sequenced whole genomes of 3,579 single cell-derived haematopoietic colonies from 10 healthy individuals spanning the human lifespan, revealing an abrupt and universal loss of clonal diversity after the age of 70 years. WHOLE-GENOME SEQUENCING OF HSC COLONIES We obtained samples from 10 individuals, with no known haematological disease, aged between 0 and 81 years (Extended Data Fig. 1a, Supplementary Table 1). One subject (KX002, a 38-year-old male) had inflammatory bowel disease treated with azathioprine and another (SX001, a 48-year0old male) had selenoprotein deficiency20, a genetic disorder not known to affect haemapoietic stem cell (HSC) dynamics. Stem cells were obtained from cord blood for the two neonates, and from bone marrow and/or peripheral blood for adult donors (Fig. 1a). Bone marrow samples were obtained peri-mortem, enabling sampling of large volumes (50–80 ml) from multiple vertebrae. [Figure: Flow-sorting strategy for single HSC/MPP and HPC cells.a, Experimental approach. b, Sorting of single human HSC/MPP and HPCs from cord blood, peripheral blood and bone marrow. Cells were stained with the panel of antibodies in Supplementary Table 1 then single HSC/MPP or HPCs were index sorted according to the strategy depicted into individual wells of 96 well plates. Image created with FlowJo v10. c, Colony forming efficiency per individual of all single HSPCs sorted. d, Box-and-whisker plots showing fluorescence intensity for different cell surface markers used to define human HSCs, with different patients in rows. CD90 and CD49f are markers used to define the short and long term HSC subsets, which were included in our panel but were not used in sorting. Cells that produced colonies large enough to sequence are shown in teal; cells that did not form large enough colonies to sequence are in orange. The horizontal lines denote the median, the boxes the interquartile range and the whiskers the range. The number (n) of ‘sequenced’ (teal) and ‘not sequenced’ (orange) colonies included for each individual are shown to the right of each panel.] [Figure: Mutational burden in normal HSC/MPPs.a, Bar plot showing the numbers of colonies sequenced from each tissue and cell type for each donor in the study. Age and sex (F, female; M, male) are indicated below the donor ID. b, Burden of single nucleotide variants across the donor cohort. The points represent individual HSC/MPP colonies (n = 3,361) and are coloured by donor as indicated in a. The grey line represents a regression of age with mutation burden, with shading indicating the 95% confidence interval. c, Burden of small indels across the donor cohort. d, Bar plot showing the number of independently acquired structural variants (SVs) per colony sequenced in each donor. The absolute number of structural variants is shown at the top of each bar. e, Bar plot showing the number of independently acquired autosomal copy number aberrations (CNAs) per colony sequenced in each donor. The absolute number of copy number aberrations is shown at the top of each bar. f, Bar plot showing the number of independently acquired Y chromosome copy number aberrations sequenced in each male donor. The absolute number of copy number aberrations is shown at the top of each bar. g, Telomere length across the donor cohort, including only those samples sequenced on the HiSeq X10 platform. Each point represents a single HSC/MPP colony. Two outlying points for CB001 are not shown (telomere lengths 16,037 bp and 21,155 bp). In b, c, g, boxes overlaid indicate the median and interquartile range and whiskers denote the minimum of either the range or 25th and 75th centile plus 1.5× interquartile range.] Single immunophenotypic HSC/MPPs (Lin−CD34+CD38−CD45RA−) were sorted using flow cytometry and cultured (Extended Data Fig. 1b). Overall, 42–89% of sorted HSC/MPPs produced colonies (Extended Data Fig. 1c), suggesting that the sequenced colonies were a representative sample of the HSC/MPP population in each individual, as supported by analysis of cell surface markers (Extended Data Fig. 1d). Haematopoietic progenitor cells (HPCs) (Lin−CD34+CD38+) were also flow-sorted for four

Read the complete text